Can we predict maternal sepsis? massive study targets racial disparities
NCT ID NCT06148532
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at 400,000 birthing people to better predict maternal sepsis, a leading cause of death in the U.S. The goal is to improve risk prediction by considering social factors like poverty and race, and to create a care model that reduces death and disability. The study focuses on Black and other underserved communities who face the highest risks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to predict and prevent maternal sepsis, especially for Black and underserved birthing people.
- What could go wrong
- This is an observational study, not a treatment trial. It may identify risk factors but won't directly test a new drug or intervention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 400,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2023
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Delivery admission records at PRC sites
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Be 18 years or older * Delivery admission (and) postpartum readmission at one of the Perinatal Research Consortium sites 2014-2021 Exclusion Criteria: * Under 18 years old * Delivery admission (and) postpartum readmission at hospital that is not in the Perinatal Research Consortium * Delivery admission before 2014 or after 2021
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infections are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Columbia Unviersity Medical Center
New York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tweaked bird flu shot build stronger immunity?
- Can software make hospital pharmacists faster and safer?
- A simple blood test may spot severe bacterial infections faster in the ER
- Can a simple shot under the skin replace an IV for a key antibiotic in the elderly?
- Experimental malaria vaccine aims to block parasite growth
- Rare disease drug shows promise in reducing infections